Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues

Abstract Background For various cancers, differences in response to treatment and subsequent survival period have been reported to be associated with variation in immune contextures. Aim We sought to identify whether such association exists in respect of gingivobuccal oral cancer. Materials and meth...

Full description

Bibliographic Details
Main Authors: Ankita Chatterjee, Amrita Chaudhary, Arnab Ghosh, Pattatheyil Arun, Geetashree Mukherjee, Indu Arun, Arindam Maitra, Nidhan Biswas, Partha P. Majumder
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6299
_version_ 1797242677860761600
author Ankita Chatterjee
Amrita Chaudhary
Arnab Ghosh
Pattatheyil Arun
Geetashree Mukherjee
Indu Arun
Arindam Maitra
Nidhan Biswas
Partha P. Majumder
author_facet Ankita Chatterjee
Amrita Chaudhary
Arnab Ghosh
Pattatheyil Arun
Geetashree Mukherjee
Indu Arun
Arindam Maitra
Nidhan Biswas
Partha P. Majumder
author_sort Ankita Chatterjee
collection DOAJ
description Abstract Background For various cancers, differences in response to treatment and subsequent survival period have been reported to be associated with variation in immune contextures. Aim We sought to identify whether such association exists in respect of gingivobuccal oral cancer. Materials and methods We performed deep immune profiling of tumor and margin tissues collected from 46 treatment naïve, Human Papillomavirus (HPV) negative, patients. Each patient was followed for 24 months and prognosis (recurrence/death) noted. Key findings were validated by comparing with TCGA‐HNSC cohort data. Results About 28% of patients showed poor post‐treatment prognosis. These patients exhibited a high probability of recurrence even within 1 year and death within 2 years. There was restricted immune cell infiltration in tumor, but not in margin, among these patients. Reduced expression of eight immune‐related genes (IRGs) (NT5E, THRA, RBP1, TLR4, ITGA6, BMPR1B, ITGAV, SSTR1) in tumor strongly predicted better quality of prognosis, both in our patient cohort and in TCGA‐HNSC cohort. Tumors of patients with better prognosis were associated with (a) lower CD73+ cells with concomitant lower expression level of NT5E/CD73, (b) higher proportions of CD4+ and CD8+ T cells, B cells, NK cells, M1 macrophages, (c) higher %Granzyme+ cells, (d) higher TCR and BCR repertoire diversities. CD73 expression in tumor was associated with low CD8+ and CD4+ T cells, low immune repertoire diversity, and advanced cancer stage. Discussion and conclusion High infiltration of anti‐tumor immune cells in both tumors and margins results in good prognosis, while in patients with minimal infiltration in tumors in spite of high infiltration in margins results in poor prognosis. Targeted CD73 immune‐checkpoint inhibition may improve clinical outcome.
first_indexed 2024-03-12T00:55:02Z
format Article
id doaj.art-3384f9e7ca7549e4b45b9511a58a7056
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-24T18:43:02Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-3384f9e7ca7549e4b45b9511a58a70562024-03-27T09:11:00ZengWileyCancer Medicine2045-76342023-08-011216167741678710.1002/cam4.6299Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissuesAnkita Chatterjee0Amrita Chaudhary1Arnab Ghosh2Pattatheyil Arun3Geetashree Mukherjee4Indu Arun5Arindam Maitra6Nidhan Biswas7Partha P. Majumder8National Institute of Biomedical Genomics Kalyani IndiaTata Medical Center Kolkata IndiaNational Institute of Biomedical Genomics Kalyani IndiaTata Medical Center Kolkata IndiaTata Medical Center Kolkata IndiaTata Medical Center Kolkata IndiaNational Institute of Biomedical Genomics Kalyani IndiaNational Institute of Biomedical Genomics Kalyani IndiaNational Institute of Biomedical Genomics Kalyani IndiaAbstract Background For various cancers, differences in response to treatment and subsequent survival period have been reported to be associated with variation in immune contextures. Aim We sought to identify whether such association exists in respect of gingivobuccal oral cancer. Materials and methods We performed deep immune profiling of tumor and margin tissues collected from 46 treatment naïve, Human Papillomavirus (HPV) negative, patients. Each patient was followed for 24 months and prognosis (recurrence/death) noted. Key findings were validated by comparing with TCGA‐HNSC cohort data. Results About 28% of patients showed poor post‐treatment prognosis. These patients exhibited a high probability of recurrence even within 1 year and death within 2 years. There was restricted immune cell infiltration in tumor, but not in margin, among these patients. Reduced expression of eight immune‐related genes (IRGs) (NT5E, THRA, RBP1, TLR4, ITGA6, BMPR1B, ITGAV, SSTR1) in tumor strongly predicted better quality of prognosis, both in our patient cohort and in TCGA‐HNSC cohort. Tumors of patients with better prognosis were associated with (a) lower CD73+ cells with concomitant lower expression level of NT5E/CD73, (b) higher proportions of CD4+ and CD8+ T cells, B cells, NK cells, M1 macrophages, (c) higher %Granzyme+ cells, (d) higher TCR and BCR repertoire diversities. CD73 expression in tumor was associated with low CD8+ and CD4+ T cells, low immune repertoire diversity, and advanced cancer stage. Discussion and conclusion High infiltration of anti‐tumor immune cells in both tumors and margins results in good prognosis, while in patients with minimal infiltration in tumors in spite of high infiltration in margins results in poor prognosis. Targeted CD73 immune‐checkpoint inhibition may improve clinical outcome.https://doi.org/10.1002/cam4.6299biomarkerCD73prognosisrecurrence, immune contexture
spellingShingle Ankita Chatterjee
Amrita Chaudhary
Arnab Ghosh
Pattatheyil Arun
Geetashree Mukherjee
Indu Arun
Arindam Maitra
Nidhan Biswas
Partha P. Majumder
Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
Cancer Medicine
biomarker
CD73
prognosis
recurrence, immune contexture
title Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
title_full Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
title_fullStr Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
title_full_unstemmed Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
title_short Overexpression of CD73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
title_sort overexpression of cd73 is associated with recurrence and poor prognosis of gingivobuccal oral cancer as revealed by transcriptome and deep immune profiling of paired tumor and margin tissues
topic biomarker
CD73
prognosis
recurrence, immune contexture
url https://doi.org/10.1002/cam4.6299
work_keys_str_mv AT ankitachatterjee overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT amritachaudhary overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT arnabghosh overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT pattatheyilarun overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT geetashreemukherjee overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT induarun overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT arindammaitra overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT nidhanbiswas overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues
AT parthapmajumder overexpressionofcd73isassociatedwithrecurrenceandpoorprognosisofgingivobuccaloralcancerasrevealedbytranscriptomeanddeepimmuneprofilingofpairedtumorandmargintissues